Eszopiclone for late-life insomnia

Insomnia, the most common sleep disturbance in later life, affects 20%–50% of older adults. Eszopiclone, a short-acting nonbenzodiazepine hypnotic agent developed for the treatment of insomnia, has been available in Europe since 1992 and in the US since 2005. Although not yet evaluated for transient...

Descripción completa

Detalles Bibliográficos
Autores principales: McCrae, Christina S, Ross, Amanda, Stripling, Ashley, Dautovich, Natalie D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685268/
https://www.ncbi.nlm.nih.gov/pubmed/18044182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685268/
https://www.ncbi.nlm.nih.gov/pubmed/18044182

Ejemplares similares